Mesoblast

About:

Mesoblast is a medicine company that develops biologic products for the broad field of regenerative medicine.

Website: http://www.mesoblast.com

Twitter/X: mesoblast

Top Investors: Hercules Capital, Novaquest Capital Management, Gregory George, Australian Government for Research & Development

Description:

Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal Precursor Cell (MPC) technology is being developed for an extensive range of major clinical diseases, including inflammatory and immunologic conditions of the joints and lungs, diabetes, and kidney disease, orthopedic spine conditions, and cardiovascular disorders.